Medical Economics November 17, 2021

The “Cures 2.0” bill, if signed into law, would expand medical research, aid development of new therapies and expand telehealth.

Editor’s note: This article was first published on Chief Healthcare Executive.

Healthcare and research advocates are cheering the introduction of a new bill that supporters say will spur new cures and therapies and expand telehealth access.

U.S. Reps. Diana DeGette, D-Colo., and Fred Upton, R-Mich., introduced the “Cures 2.0” bill Tuesday. The measure would create the new federal research agency proposed by President Joe Biden: the Advanced Research Projects Agency for Health, or ARPA-H.

The bill would offer $6.5 billion to finance the agency for three years, the amount the White House requested.

The agency is designed to undertake novel,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Cures Act, Digital Health, Govt Agencies, Health IT, Provider, Technology, Telehealth
What Washington wants in Cures 2.0
How ONC Can Strengthen Its HTI-1 Rule To Ensure Transparency, Fairness, And Equity In AI
Providers Take Note: The Common Agreement Version 2.0 Released
Advancing Nationwide, Trusted Health Information Networks
Cures Act tied to quicker release, access of imaging reports

Share This Article